hill-rom holdings inc (HRC) Key Developments
Hill-Rom Holdings, Inc. Announces Board Changes
Mar 5 15
Hill-Rom Holdings, Inc. announced that Stacy Enxing Seng has been elected to its Board of Directors. She most recently served as an Executive in Residence for Covidien. Ms. Enxing Seng currently serves on the boards of Sonova Holding AG, Solace Therapeutics. Joanne Smith, M.D., is retiring from the Hill-Rom Board after 12 years of service.
Hill-Rom Holdings, Inc. Declares Second Quarter Dividend, Payable on March 31, 2015
Mar 4 15
Hill-Rom Holdings, Inc. announced that its board of directors declared a fiscal year 2015 second quarter dividend of $0.16 per share. The dividend is payable on March 31, 2015 to shareholders of record as of the close of business on March 17, 2015. This quarterly dividend represents a 5% increase over the amount paid a year ago as well as the amount paid last quarter. The annualized dividend rate per share will increase to $0.64 from $0.61.
Hill-Rom Holdings Eyes Acquisitions
Feb 6 15
Hill-Rom Holdings, Inc. (NYSE:HRC) has developed a strategy to improve longer-term margins which will include margin accretive acquisitions and additional operational initiatives.
Hill-Rom Holdings, Inc. Announces Unaudited Consolidated Earnings Results for First Quarter Ended Dec. 31, 2014; Provides Earnings Guidance for the Second Quarter of Fiscal 2015; Revised Earnings Guidance for Fiscal 2015
Feb 3 15
Hill-Rom Holdings, Inc. announced unaudited consolidated earnings results for first quarter ended Dec. 31, 2014. For the quarter, the company reported total revenue of $465 million, operating profit of $19.3 million, net income of $12.1 million or $0.21 diluted per share and net cash provided by operating activities of $31 million compared to the total revenue of $393.4 million, operating profit of $21.4 million, net income of $13.2 million or $0.22 diluted per share and net cash provided by operating activities of $42.3 million for the same quarter a year ago. Operating cash flow was, down primarily due to outflows from restructuring and acquisition integration. Capital expenditures increased by $28 million, due primarily to increased investment in its rental fleet.
For the second quarter of fiscal 2015, the company expects reported revenue growth of 13% to 15%. This reflects the following assumptions: low to mid-single digit constant currency organic revenue growth and a negative impact from currency of approximately 4%. Second quarter adjusted earnings per diluted share are expected to be $0.57 to $0.60.
Fiscal year 2015 adjusted earnings per share are expected to be $2.44 to $2.50; Full-year reported revenue is expected to grow 11% to 12%. The company's guidance for full year adjusted earnings per diluted share is $2.44 to $2.50 compared to $2.42 to $2.48 previously. The company expects cash flow from operations for the full year to be approximately $250 million, unchanged from prior guidance. Compared to its prior range of 11% to 13%, this reflects slightly stronger constant currency revenue growth, driven by North America capital, offset by the negative impact of the stronger dollar. Its forecast is underpinned by the following assumptions: low single-digit constant currency organic revenue growth and a negative currency impact of approximately 4% compared to the 1% to 2% expectations in its prior guidance. More specifically, this outlook reflects the following: low to mid-single digit revenue growth in North America, up from its prior guidance range of low single-digit growth; flat international constant currency revenue; Surgical and Respiratory Care organic constant currency revenue growth in the low single digits; gross margin of approximately 45%, a slight decrease from its prior guidance of 45% to 46%; R&D spending of approximately 4% to 5% of sales; SG&A that is improving as a percentage of sales; a tax rate of approximately 29% to 30% compared to prior guidance of 30% to 31%, which reflects the benefit of the R&D tax credit reinstatement; and approximately 58 million shares outstanding for the year. The company continues to project 2015 operating cash flow to be approximately $250 million. The company anticipates capital expenditures of approximately $140 million, up from its prior guidance of $110 million. This increase is driven primarily by additional investment in its rental fleet to support expected volume increases from recent contract wins.
Hill-Rom Holdings, Inc., Annual General Meeting, Mar 04, 2015
Jan 22 15
Hill-Rom Holdings, Inc., Annual General Meeting, Mar 04, 2015., at 10:00 Central Standard Time. Location: 180 North Stetson Avenue. Agenda: To discuss election of directors; to discuss non-binding vote on executive compensation; to discuss ratification of the appointment of the independent registered public accounting firm; and to discuss and transact any other items of business that may properly be brought before the meeting and any postponement or adjournment thereof.